NM_153704.6:c.725A>G
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_153704.6(TMEM67):c.725A>G(p.Asn242Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000929 in 1,614,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_153704.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251250Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135778
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461812Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 727198
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152282Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74470
ClinVar
Submissions by phenotype
not provided Pathogenic:3
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26260382, 29302074, 25920555, 26092869, 30315573, 32000717, 33726816, 35032046, 28719906, 27491411) -
- -
- -
Joubert syndrome 6 Pathogenic:3
A generation of sequencing tests were performed on the foetus's parents and the prior witness: the father carried c. 475 T >C;Het, mother carrying c. 725A> G;Het, daughter carrying c. 475 T >C; c. 725A> G double heterozygous, the fetus and the first witness inherited the genetic mutations of both parents -
- -
The homozygous p.Asn242Ser variant in TMEM67 was identified by our study in one individual with Joubert syndrome. The p.Asn242Ser variant in TMEM67 was reported in 23 individuals (including 22 Iranians) with Joubert syndrome, segregated with disease in 22 affected relatives from 9 families (PMID: 28719906, 19574260), and has been identified in 0.002978% (1/33580) of Latino chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs775883520). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency and its prevalence in Iranian families with a shared haplotype suggests this is a founder variant (PMID: 28719906). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. This variant was also reported likely pathogenic in ClinVar prior to the publication of a paper about 22 Iranians from 9 families with this variant and Joubert syndrome (Variation ID: 216826). Two additional variants at the the same position, p.Asn242Thr and p.Asn242Lys, have been reported in association with disease in the literature, supporting that a change at this position may not be tolerated (PMID: 23559409, 19574260). Position 242 in the TMEM67 protein has also been reported as a glycosylation site for GlcNAc, providing additional support that a change in this position may not be tolerated (Entry: Q5HYA8) In summary, this variant meets criteria to be classified as pathogenic for Joubert syndrome in an autosomal recessive manner based on the predicted impact of a change at position 242 in TMEM67 and cosegregation with Joubertssyndrome in multiple Iranian families. ACMG/AMP Criteria applied: PM2, PP3, PM5, PM1_Supporting, PP1_Strong (Richards 2015). -
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis Pathogenic:1
This missense change has been observed in individual(s) with Joubert syndrome (PMID: 26092869, 27491411, 28719906). It has also been observed to segregate with disease in related individuals. For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TMEM67 protein function. ClinVar contains an entry for this variant (Variation ID: 216826). This variant is present in population databases (rs775883520, gnomAD 0.003%). This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 242 of the TMEM67 protein (p.Asn242Ser). -
Nephronophthisis 11 Pathogenic:1
PM2, PP3, PM5, PM1_Supporting, PP1_Strong -
Inborn genetic diseases Pathogenic:1
- -
Meckel syndrome, type 3;C1853153:Joubert syndrome 6;C1865794:RHYNS syndrome;C2673874:Bardet-Biedl syndrome 14;C3150796:Nephronophthisis 11;C5435651:COACH syndrome 1 Pathogenic:1
- -
COACH syndrome 1 Pathogenic:1
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.84; 3Cnet: 0.91). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000216826). Different missense changes at the same codon (p.Asn242Lys, p.Asn242Thr) have been reported to be associated with TMEM67 -related disorder (PMID: 19574260 , 23559409). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -
Abnormality of the nervous system Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at